Expression and ultrastructural localization of HMB-45 antigen

Area of Science:

• Cell Biology
• Immunohistochemistry
• Melanoma Research

Background:

• HMB-45 is a monoclonal antibody used to identify melanoma cells and developing melanocytes.
• Understanding HMB-45 binding sites is crucial for melanoma diagnosis and understanding melanogenesis.
• Melanogenesis involves the formation and maturation of melanosomes, the organelles responsible for melanin production.

Purpose of the Study:

• To investigate the expression and subcellular localization of the HMB-45 antigen in various melanocyte types.
• To determine if HMB-45 binding differs between neoplastic and non-neoplastic melanocytes.
• To examine HMB-45 localization in melanocytes from normal fetuses, infants with oculocutaneous albinism, and melanoma cell lines.

Main Methods:

• Utilized post-embedding immunogold electron microscopy for high-resolution subcellular analysis.
• Employed rapid freezing and freeze substitution fixation to preserve delicate antigen properties without chemical fixatives.
• Examined HMB-45 expression in epidermal melanocytes, melanoma cell lines (G361, MeWo), and in vivo melanoma samples.

Main Results:

• HMB-45 antigen was detected in neoplastic melanocytes, normal fetal melanocytes, and melanocytes from infants.
• In neoplastic melanocytes, HMB-45 localized to stages I and II melanosomes.
• In normal fetal and infant melanocytes, HMB-45 was mainly on stages II and III melanosomes; in tyrosinase-negative oculocutaneous albinism, it was on stages I and II.

Conclusions:

• HMB-45 primarily binds to immature melanosomes (stages I and II) during melanogenesis in both neoplastic and non-neoplastic cells.
• The intracytoplasmic localization of HMB-45 within melanosomes differs based on the melanocyte's condition.
• HMB-45's binding to immature melanosomes is independent of tyrosinase activity.